TZP-301

N/A

Report date: 2025/06/11 20:01:15
NME

Base Information

Drug NameTZP-301
Drug Alias NameTZP-300 series (Tranzyme)TZP-300 series (Ocera)TZP-301TZP-300
ClassificationSmall molecules
Mechanisms of ActionGhrelin/growth hormone secretagogue receptor antagonistsAppetite suppressant
TargetsGhrelin/growth hormone secretagogue receptor
Therapy Area/IndicationsSyndromeObesity
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesTranzyme Pharma Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesTranzyme Pharma IncOcera Therapeutics Inc
Active IndicationsN/A
Inactive IndicationsSyndromeObesity

Other Information

ATC CodeN/A
Related LinksN/A